Claude Labrie

1.0k total citations
22 papers, 887 citations indexed

About

Claude Labrie is a scholar working on Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Claude Labrie has authored 22 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 13 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Claude Labrie's work include Estrogen and related hormone effects (11 papers), Virus-based gene therapy research (6 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Claude Labrie is often cited by papers focused on Estrogen and related hormone effects (11 papers), Virus-based gene therapy research (6 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Claude Labrie collaborates with scholars based in Canada and United States. Claude Labrie's co-authors include Jacques Simard, Fernand Labrie, Alain Bélanger, Van Luu‐The, Fernand Labrie, Michael B. Mathews, Gilbert F. Morris, Fernand Labrie, Frédéric Pouliot and Shouqi Luo and has published in prestigious journals such as Nucleic Acids Research, Molecular and Cellular Biology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Claude Labrie

22 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claude Labrie Canada	15	442	395	307	127	109	22	887
E. Perel Canada	16	466 1.1×	233 0.6×	184 0.6×	134 1.1×	97 0.9×	20	829
A.A.J. van Landeghem Netherlands	10	450 1.0×	138 0.3×	224 0.7×	172 1.4×	71 0.7×	18	819
M. Perrot-Applanat France	11	367 0.8×	235 0.6×	399 1.3×	122 1.0×	89 0.8×	15	856
A.E. Colás United States	15	172 0.4×	186 0.5×	244 0.8×	93 0.7×	63 0.6×	45	742
P.F. Brenner United States	11	372 0.8×	365 0.9×	161 0.5×	76 0.6×	336 3.1×	15	1.0k
E Fugassa Italy	19	196 0.4×	453 1.1×	408 1.3×	42 0.3×	282 2.6×	65	1.1k
Zeenat A. Shyr United States	17	282 0.6×	397 1.0×	640 2.1×	62 0.5×	119 1.1×	28	1.6k
Cheol Yi Hong South Korea	18	288 0.7×	143 0.4×	490 1.6×	130 1.0×	147 1.3×	35	1.2k
Edward Simpson United States	16	467 1.1×	111 0.3×	428 1.4×	222 1.7×	83 0.8×	35	1.1k
Virginia H. Black United States	17	112 0.3×	264 0.7×	496 1.6×	38 0.3×	95 0.9×	47	939

Countries citing papers authored by Claude Labrie

Since Specialization

Citations

This map shows the geographic impact of Claude Labrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Labrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Labrie more than expected).

Fields of papers citing papers by Claude Labrie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Labrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Labrie. The network helps show where Claude Labrie may publish in the future.

Co-authorship network of co-authors of Claude Labrie

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Labrie. A scholar is included among the top collaborators of Claude Labrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Labrie. Claude Labrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Barbier, Olivier, Caroline Albert, Isabelle Martineau, et al.. (2001). Glucuronidation of the Nonsteroidal Antiestrogen EM-652 (SCH 57068), by Human and Monkey Steroid Conjugating UDP-Glucuronosyltransferase Enzymes. Molecular Pharmacology. 59(3). 636–645. 15 indexed citations

2.

Labrie, Fernand, Claude Labrie, Alain Bélanger, et al.. (2001). EM-652 (SCH57068), a pure SERM having complete antiestrogenic activity in the mammary gland and endometrium. The Journal of Steroid Biochemistry and Molecular Biology. 79(1-5). 213–225. 40 indexed citations

3.

Labrie, Fernand, Van Luu‐The, Claude Labrie, & Jacques Simard. (2001). DHEA and Its Transformation into Androgens and Estrogens in Peripheral Target Tissues: Intracrinology. Frontiers in Neuroendocrinology. 22(3). 185–212. 292 indexed citations

4.

Barbier, Olivier, Caroline Albert, Isabelle Martineau, et al.. (2001). Glucuronidation of the Nonsteroidal Antiestrogen EM-652 (SCH 57068), by Human and Monkey Steroid Conjugating UDP-Glucuronosyltransferase Enzymes. Molecular Pharmacology. 59(3). 636–645. 2 indexed citations

5.

Tatchum‐Talom, Rabelais, Céline Martel, Claude Labrie, Fernand Labrie, & André Marette. (2000). Gender Differences in Hemodynamic Responses to Endothelin-1. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S102–S104. 14 indexed citations

6.

Labrie, Claude, Sylvain Gauthier, Yves Mérand, et al.. (2000). Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude mice. International Journal of Cancer. 85(3). 424–429. 9 indexed citations

7.

Pouliot, Frédéric & Claude Labrie. (1999). Expression profile of agonistic Smads in human breast cancer cells: Absence of regulation by estrogens. International Journal of Cancer. 81(1). 98–103. 28 indexed citations

8.

Labrie, Fernand, et al.. (1999). Effects of the antiestrogen EM-800 (SCH 57050) and cyclophosphamide alone and in combination on growth of human ZR-75-1 breast cancer xenografts in nude mice.. PubMed. 59(20). 5176–80. 8 indexed citations

9.

Labrie, Claude, et al.. (1998). Effect of Dehydroepiandrosterone and the Antiestrogen EM-800 on Growth of Human ZR-75-1 Breast Cancer Xenografts. JNCI Journal of the National Cancer Institute. 90(10). 772–778. 33 indexed citations

10.

Luo, Shouqi, Céline Martel, Sylvain Gauthier, et al.. (1997). Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice. International Journal of Cancer. 73(5). 735–739. 19 indexed citations

11.

Luo, Shouqi, Céline Martel, Antigone Sourla, et al.. (1997). Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice. International Journal of Cancer. 73(3). 381–391. 45 indexed citations

12.

Sourla, Antigone, Shouqi Luo, Claude Labrie, Alain Bélanger, & Fernand Labrie. (1997). Morphological Changes Induced by 6-Month Treatment of Intact and Ovariectomized Mice with Tamoxifen and the Pure Antiestrogen EM-800. Endocrinology. 138(12). 5605–5617. 35 indexed citations

13.

Labrie, Claude, Benjamin H. Lee, & Michael B. Mathews. (1995). Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter. Nucleic Acids Research. 23(18). 3732–3741. 33 indexed citations

14.

Morris, Gilbert F., Claude Labrie, & Michael B. Mathews. (1994). Modulation of transcriptional activation of the proliferating cell nuclear antigen promoter by the adenovirus E1A 243-residue oncoprotein depends on proximal activators. Molecular and Cellular Biology. 14(1). 543–553. 10 indexed citations

15.

Labrie, Claude, Gilbert F. Morris, & Michael B. Mathews. (1993). A Complex Promoter Element Mediates Transactivation of the Human Proliferating Cell Nuclear Antigen Promoter by the 243-Residue Adenovirus E1A Oncoprotein. Molecular and Cellular Biology. 13(3). 1697–1707. 10 indexed citations

16.

Kannabiran, Chitra, Gilbert F. Morris, Claude Labrie, & Michael B. Mathews. (1993). The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoter. Journal of Virology. 67(1). 507–515. 31 indexed citations

17.

Trudel, Claude, Jacques Couët, Céline Martel, Claude Labrie, & Fernand Labrie. (1991). Regulation of Adrenal 3β-Hydroxysteroid Dehydrogenase/Δ⁵-δ⁴-Isomerase Expression and Activity by Adrenocorticotropin and Corticosterone in the Rat*. Endocrinology. 129(4). 2077–2084. 12 indexed citations

18.

Luu‐The, Van, Claude Labrie, Huifen Zhao, et al.. (1990). Purification, Cloning, Complementary DNA Structure, and Predicted Amino Acid Sequence of Human Estradiol 17β‐Dehydrogenase. Annals of the New York Academy of Sciences. 595(1). 40–52. 23 indexed citations

19.

Simard, Jacques, Claude Labrie, Jean‐François Hubert, & Fernand Labrie. (1988). OVERVIEW: Modulation by Sex Steroids and [d-TRP⁶, Des-Gly-NH₂¹⁰]Luteinizing Hormone (LH)-Releasing Hormone Ethylamide of α-Subunit and LHβ Messenger Ribonucleic Acid Levels in the Rat Anterior Pituitary Gland. Molecular Endocrinology. 2(9). 775–784. 26 indexed citations

20.

Labrie, Claude, Alain Bélanger, & Fernand Labrie. (1988). Androgenic Activity of Dehydroepiandrosterone and Androstenedione in the Rat Ventral Prostate. Endocrinology. 123(3). 1412–1417. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact